The successful development of biologics requires cmc development along with clinical development, including ensuring the readiness of manufacturing facilities for commercial production Explore the full cell bank lifecycle for biologics and cell & gene therapies—from rcb to eopcb Learn gmp best practices, testing strategies, and regulatory insights to support robust manufacturing and successful bla/maa submissions. Lifecycle management our cgmp manufacturing services are designed to support the entire lifecycle of your biologic product Our goal is to ensure sustained product quality, supply chain reliability, and regulatory compliance throughout your biologic’s lifecycle. We offer flexible solutions for the entire lifecycle of your product, from preclinical to commercial stages
Depending on the needs of your molecule and your program, we can utilize our global network and capabilities to offer the appropriate suite of services The variety of our offerings provides the flexibility of a complete program, from gene to drug product, or the option to drop in at a. Guidelines focus on lifecycle management the biomanufacturing industry’s increased attention to lifecycle management has been driven by management and mitigation as a result of the fda’s “pharmaceutical cgmps for the 21st century” initiative Assays conducted at several stages of a biologic’s lifecycle include assessment of both protein and drug product stability Lifecycle management must account for bioprocess adjustments across biologics to address contamination and stability, ensuring ongoing compliance with regulatory expectations scaling up The life cycle of analytical methods plays a critical aspect of biological product development
OPEN
